203 related articles for article (PubMed ID: 21155917)
1. Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
Imani F; Boada FE; Lieberman FS; Davis DK; Deeb EL; Mountz JM
J Neuroimaging; 2012 Apr; 22(2):184-90. PubMed ID: 21155917
[TBL] [Abstract][Full Text] [Related]
2. Molecular and metabolic pattern classification for detection of brain glioma progression.
Imani F; Boada FE; Lieberman FS; Davis DK; Mountz JM
Eur J Radiol; 2014 Feb; 83(2):e100-5. PubMed ID: 24321226
[TBL] [Abstract][Full Text] [Related]
3. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
4. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of 18F-FDG PET-CT and MRI in identifying and grading gliomas.
Song PJ; Lu QY; Li MY; Li X; Shen F
J Biol Regul Homeost Agents; 2016; 30(3):833-838. PubMed ID: 27655507
[TBL] [Abstract][Full Text] [Related]
6. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
Morana G; Piccardo A; Puntoni M; Nozza P; Cama A; Raso A; Mascelli S; Massollo M; Milanaccio C; Garrè ML; Rossi A
Neuro Oncol; 2015 Dec; 17(12):1637-47. PubMed ID: 26405202
[TBL] [Abstract][Full Text] [Related]
8. [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.
Collet S; Valable S; Constans JM; Lechapt-Zalcman E; Roussel S; Delcroix N; Abbas A; Ibazizene M; Bernaudin M; Barré L; Derlon JM; Guillamo JS
Neuroimage Clin; 2015; 8():448-54. PubMed ID: 26106569
[TBL] [Abstract][Full Text] [Related]
9. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.
Kim ES; Satter M; Reed M; Fadell R; Kardan A
Neuroradiol J; 2016 Jun; 29(3):193-7. PubMed ID: 27122050
[TBL] [Abstract][Full Text] [Related]
10. Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy.
Yoon JH; Kim JH; Kang WJ; Sohn CH; Choi SH; Yun TJ; Eun Y; Song YS; Chang KH
Eur Radiol; 2014 Feb; 24(2):380-9. PubMed ID: 24078054
[TBL] [Abstract][Full Text] [Related]
11. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
12. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
13. Prediction of pathology and survival by FDG PET in gliomas.
Padma MV; Said S; Jacobs M; Hwang DR; Dunigan K; Satter M; Christian B; Ruppert J; Bernstein T; Kraus G; Mantil JC
J Neurooncol; 2003 Sep; 64(3):227-37. PubMed ID: 14558598
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
Lichy MP; Henze M; Plathow C; Bachert P; Kauczor HU; Schlemmer HP
Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
[TBL] [Abstract][Full Text] [Related]
16. A surgical strategy using a fusion image constructed from 11C-methionine PET, 18F-FDG-PET and MRI for glioma with no or minimum contrast enhancement.
Ideguchi M; Nishizaki T; Ikeda N; Okamura T; Tanaka Y; Fujii N; Ohno M; Shimabukuro T; Kimura T; Ikeda E; Suga K
J Neurooncol; 2018 Jul; 138(3):537-548. PubMed ID: 29516344
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma.
Shaw TB; Jeffree RL; Thomas P; Goodman S; Debowski M; Lwin Z; Chua B
J Med Imaging Radiat Oncol; 2019 Oct; 63(5):650-656. PubMed ID: 31368665
[TBL] [Abstract][Full Text] [Related]
18. Spatial Relationship of Glioma Volume Derived from
Mauler J; Maudsley AA; Langen KJ; Nikoubashman O; Stoffels G; Sheriff S; Lohmann P; Filss C; Galldiks N; Kops ER; Shah NJ
J Nucl Med; 2018 Apr; 59(4):603-609. PubMed ID: 28848036
[TBL] [Abstract][Full Text] [Related]
19. Integrated PET-MRI for Glioma Surveillance: Perfusion-Metabolism Discordance Rate and Association With Molecular Profiling.
Seligman L; Kovanlikaya I; Pisapia DJ; Naeger DM; Magge R; Fine HA; Chiang GC
AJR Am J Roentgenol; 2019 Apr; 212(4):883-891. PubMed ID: 30779663
[TBL] [Abstract][Full Text] [Related]
20. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
